Chronic Disease Management, Chronic Respiratory Conditions, Pulmonary Diseases or Conditions, Respiration Disorders, Respiratory Tract Disorders
Conditions
Keywords
Lung Care, Breathe-Easy, Dietary supplement
Brief summary
The trial aims to assess the effectiveness of a natural lung care solution and a food supplement in improving lung function, capacity, and alleviating symptoms associated with respiratory conditions like asthma, COPD, and chronic bronchitis.
Interventions
DIETARY_SUPPLEMENTLung Care Solution
Participants in the Breathe-Easy group received the food supplement solution designed to improve lung health and respiratory function. The supplement includes natural ingredients known for their potential to reduce inflammation, improve oxygen utilization, and support overall lung capacity. Participants used 1 teaspoon of the supplement, prepared as a tea decoction, twice daily.
OTHERSupport treatment
Participants in this group engaged in guided lifestyle modifications aimed at improving respiratory health. This included dietary recommendations as part of clinical practice.
Sponsors
Mettle Networks
Gyansanjeevani India
Innowage Limited
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Adults aged 18 and older. * Diagnosed with a chronic respiratory condition (e.g., asthma, COPD). * No known allergies to ingredients in the supplement. * Ability to provide informed consent and comply with study procedures.
Exclusion criteria
* Acute respiratory infection within the last 30 days. * Current participation in another clinical trial. * History of severe adverse reactions to similar supplements.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in pulmonary function | Change in forced expiratory volume (FEV1) from baseline to 12 weeks. | Differences in forced expiratory volume measured by spirometry |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Symptom Severity Scores | Change in symptom scores from baseline to 12 weeks. | Symptom severity assessed to measure the impact of the interventions on respiratory symptoms such as shortness of breath, coughing, wheezing, and chest tightness. |
| Quality of Life (QoL) | Change in quality of life from baseline to 12 weeks. | QoL measured using the St. George's Respiratory Questionnaire (SGRQ) |
Countries
India
Outcome results
None listed